Clinical Trial Update: The Safety and Efficacy of Alverine in the Treatment of Cirrhotic Portal Hypertension [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update indicates evaluation of alverine for cirrhotic portal hypertension in Phase 2 and Phase 3, with the study currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cirrhosis
• Portal Hypertension

Drugs mentioned

• Alverine (Alverine citrate)

Snippet

Sponsor: Shanghai Changzheng Hospital | Conditions: Hypertension, Portal | Phase 2, Phase 3 | Status: NOT_YET_RECRUITING